176 related articles for article (PubMed ID: 16582862)
1. Re: Vaccaro AR, Patel T, Fischgrund J, et al. A pilot study evaluating safety and efficacy of OP-1 putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004;29:1885-92.
Bagaria V
Spine (Phila Pa 1976); 2006 Apr; 31(7):851; author reply 851-2. PubMed ID: 16582862
[No Abstract] [Full Text] [Related]
2. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
[TBL] [Abstract][Full Text] [Related]
3. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
Eur Spine J; 2003 Oct; 12(5):495-500. PubMed ID: 12908103
[TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study.
Vaccaro AR; Lawrence JP; Patel T; Katz LD; Anderson DG; Fischgrund JS; Krop J; Fehlings MG; Wong D
Spine (Phila Pa 1976); 2008 Dec; 33(26):2850-62. PubMed ID: 19092614
[TBL] [Abstract][Full Text] [Related]
5. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study.
Vaccaro AR; Anderson DG; Patel T; Fischgrund J; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
Spine (Phila Pa 1976); 2005 Dec; 30(24):2709-16. PubMed ID: 16371892
[TBL] [Abstract][Full Text] [Related]
6. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis.
Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
Spine (Phila Pa 1976); 2004 Sep; 29(17):1885-92. PubMed ID: 15534410
[TBL] [Abstract][Full Text] [Related]
7. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
Eur Spine J; 2005 Sep; 14(7):623-9. PubMed ID: 15672240
[TBL] [Abstract][Full Text] [Related]
8. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
10. Re: Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006; 31:2534-40.
Gill JB
Spine (Phila Pa 1976); 2007 Mar; 32(6):708; author reply 708. PubMed ID: 17413480
[No Abstract] [Full Text] [Related]
11. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
[TBL] [Abstract][Full Text] [Related]
12. OP-1 Compared with Iliac Crest Autograft in Instrumented Posterolateral Fusion: A Randomized, Multicenter Non-Inferiority Trial.
Delawi D; Jacobs W; van Susante JL; Rillardon L; Prestamburgo D; Specchia N; Gay E; Verschoor N; Garcia-Fernandez C; Guerado E; Quarles van Ufford H; Kruyt MC; Dhert WJ; Oner FC
J Bone Joint Surg Am; 2016 Mar; 98(6):441-8. PubMed ID: 26984911
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers.
Glassman SD; Dimar JR; Burkus K; Hardacker JW; Pryor PW; Boden SD; Carreon LY
Spine (Phila Pa 1976); 2007 Jul; 32(15):1693-8. PubMed ID: 17621221
[TBL] [Abstract][Full Text] [Related]
14. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
Park DK; Kim SS; Thakur N; Boden SD
Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
[TBL] [Abstract][Full Text] [Related]
16. Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short-segment posterior lumbar fusion.
Carragee EJ; Bono CM; Scuderi GJ
Spine J; 2009 Nov; 9(11):873-9. PubMed ID: 19850231
[No Abstract] [Full Text] [Related]
17. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
[TBL] [Abstract][Full Text] [Related]
18. RE: complications attributable to the use of rhBMP-2 inside the femoral ring allograft during anterior lumbar interbody fusion.
Smoljanovic T; Pecina M
Spine J; 2008; 8(2):413-4; author reply 414. PubMed ID: 18178134
[No Abstract] [Full Text] [Related]
19. Are We at the End of the Bone Morphogenetic Protein Era? Commentary on an article by Diyar Delawi, MD, PhD, et al.: "OP-1 Compared with Iliac Crest Autograft in Instrumented Posterolateral Fusion. A Randomized, Multicenter Non-Inferiority Trial".
Coe JD
J Bone Joint Surg Am; 2016 Mar; 98(6):e23. PubMed ID: 26984923
[No Abstract] [Full Text] [Related]
20. Recent article by Shields et al titled "adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion".
Bennett M; Reynolds AS; Dickerman RD
Spine (Phila Pa 1976); 2006 Aug; 31(17):2029-30. PubMed ID: 16924224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
